IQ-AI subsidiary Imaging Biometrics shares latest progress on Phase I brain cancer study

IQ-AI subsidiary Imaging Biometrics CEO Michael Schmainda shares the latest progress on the group has made on its Phase I brain cancer clinical trial it has...

Related Keywords

Michael Schmainda ,College Of Wisconsin ,Imaging Biometrics ,Medical College ,